Biotechnology in Hong Kong: Volume II Publication

August 17, 2015

SinoVeda Canada Inc. is pleased to announce the forthcoming publication of Biotechnology in Hong Kong: Volume II, which includes a chapter written by company president Dr. Yun Tam, “Transforming Traditional Chinese Medicine to Mainstream Pharmaceuticals.” This chapter describes SinoVeda’s patented Pharmaceutical Platform Technology (PPT)®, the science supporting its efficacy, and its possible commercial applications.

Retirement of Paul H. Braconnier

October 23, 2014

SinoVeda Canada today announced the retirement of Paul H. Braconnier from our Board of Directors. Mr. Braconnier has been a valuable member of our team and we wish him well in his active retirement. SinoVeda CFO Al Gourley has been appointed to the Board in his stead.

Positive clinical results for EffectiCal® compared to Caltrate®

May 21, 2014

EDMONTON, Alberta (May 21, 2014 ): SinoVeda Canada Inc. today announces positive clinical results for EffectiCal® from its 24-week double-blind, randomized comparative clinical trial in post-menopausal women.

The results showed that EffectiCal®, a supplement containing 300mg of calcium, was equally as effective as Caltrate® (600mg calcium) and vitamin D3 in measurements of bone formation and bone resorption. Additionally, subjects in this study who received EffectiCal® had significantly fewer gastrointestinal side effects than those taking Caltrate®.

1 6 7 8